Similarly, there was no difference in immunohistochemical expression of podocin in these groups of diseases i.e. primary podocytopathies (MCD and FSGS) and cases with secondary podocytopathies MGN and IgAN. The gene discussed is NPHS2; the disease is focal segmental glomerulosclerosis.